He, Chunbai
Duan, Xiaopin
Guo, Nining
Chan, Christina
Poon, Christopher
Weichselbaum, Ralph R.
Lin, Wenbin
Article History
Received: 6 January 2016
Accepted: 8 July 2016
First Online: 17 August 2016
Competing interests
: W. L. is the founder of Coordination Pharmaceuticals, Inc., which licenses the NCP technology from the University of Chicago. R.R.W. is a consultant to Coordination Pharmaceuticals, Inc. All other authors declare no competing financial interest.